Xiang-Yang Tan

Title: Xiang-Yang Tan: Innovator in Biomedicine

Introduction

Xiang-Yang Tan is a prominent inventor based in Reading, MA (US). He has made significant contributions to the field of biomedicine, particularly in the development of therapies targeting growth and differentiation factor-8 (GDF8). With a total of 16 patents to his name, his work has the potential to impact the treatment of various degenerative disorders.

Latest Patents

Tan's latest patents include groundbreaking innovations such as "Antibody to GDF8 and uses thereof." This patent discloses novel molecules related to GDF8, including specific epitopes and antagonists that can inhibit GDF8 activity both in vitro and in vivo. The patent also outlines an immunoassay for detecting and quantifying GDF8, along with methods for diagnosing and treating GDF8-associated disorders, such as muscle and bone degenerative conditions. Another significant patent is "Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8." This patent focuses on mouse and humanized antibodies that inhibit GDF-8 activity, providing methods for diagnosing and treating conditions like amyotrophic lateral sclerosis (ALS).

Career Highlights

Throughout his career, Tan has worked with notable companies such as Wyeth and Pfizer Corporation. His experience in these organizations has contributed to his expertise in biomedicine and innovation.

Collaborations

Tan has collaborated with several professionals in his field, including Lioudmila Tchistiakova and Riyez Karim. These collaborations have likely enhanced his research and development efforts.

Conclusion

Xiang-Yang Tan is a distinguished inventor whose work in biomedicine continues to pave the way for innovative treatments targeting GDF8-related disorders. His contributions are invaluable to the advancement of medical science and patient care.